- Home
- PBYI vs ISRL Comparison
PBYI vs ISRL Comparison
Compare PBYI & ISRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- ISRL
- Stock Information
- Founded
- PBYI 2010
- ISRL 2021
- Country
- PBYI United States
- ISRL United States
- Employees
- PBYI N/A
- ISRL N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- ISRL Blank Checks
- Sector
- PBYI Health Care
- ISRL Finance
- Exchange
- PBYI Nasdaq
- ISRL Nasdaq
- Market Cap
- PBYI 153.2M
- ISRL 145.6M
- IPO Year
- PBYI N/A
- ISRL 2023
- Fundamental
- Price
- PBYI $2.97
- ISRL $11.36
- Analyst Decision
- PBYI Strong Buy
- ISRL
- Analyst Count
- PBYI 1
- ISRL 0
- Target Price
- PBYI $7.00
- ISRL N/A
- AVG Volume (30 Days)
- PBYI 821.3K
- ISRL 35.6K
- Earning Date
- PBYI 02-27-2025
- ISRL 01-01-0001
- Dividend Yield
- PBYI N/A
- ISRL N/A
- EPS Growth
- PBYI 492.79
- ISRL N/A
- EPS
- PBYI 0.47
- ISRL 0.26
- Revenue
- PBYI $243,569,000.00
- ISRL N/A
- Revenue This Year
- PBYI N/A
- ISRL N/A
- Revenue Next Year
- PBYI N/A
- ISRL N/A
- P/E Ratio
- PBYI $6.38
- ISRL $43.53
- Revenue Growth
- PBYI 6.30
- ISRL N/A
- 52 Week Low
- PBYI $2.23
- ISRL $10.69
- 52 Week High
- PBYI $7.73
- ISRL $11.50
- Technical
- Relative Strength Index (RSI)
- PBYI 45.95
- ISRL 51.41
- Support Level
- PBYI $2.92
- ISRL $11.30
- Resistance Level
- PBYI $4.06
- ISRL $11.50
- Average True Range (ATR)
- PBYI 0.27
- ISRL 0.02
- MACD
- PBYI -0.03
- ISRL 0.00
- Stochastic Oscillator
- PBYI 4.39
- ISRL 30.00
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About ISRL Israel Acquisitions Corp
Israel Acquisitions Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.